0000899243-20-028904.txt : 20201021 0000899243-20-028904.hdr.sgml : 20201021 20201021165646 ACCESSION NUMBER: 0000899243-20-028904 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200723 FILED AS OF DATE: 20201021 DATE AS OF CHANGE: 20201021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hallal David CENTRAL INDEX KEY: 0001457477 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39401 FILM NUMBER: 201250977 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS, INC STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iTeos Therapeutics, Inc. CENTRAL INDEX KEY: 0001808865 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-204-4583 MAIL ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2020-07-23 2020-07-24 0 0001808865 iTeos Therapeutics, Inc. ITOS 0001457477 Hallal David C/O ITEOS THERAPEUTICS, INC. 139 MAIN STREET CAMBRIDGE MA 02142 1 0 0 0 Stock Option (Right to Buy) 19.00 2020-07-23 4 A 0 16608 0.00 A 2030-07-23 Common Stock 16608 0 D This amendment is being filed solely for the purpose of correcting the vesting schedule, as follows: this stock option shall vest on the earlier of (i) the first anniversary of the grant date or (ii) the Company's next annual meeting of stockholders following the grant date, subject to continued service through the applicable vesting date. /s/ Michel Detheux, as Attorney-in-Fact 2020-10-21